Pages that link to "Q43157289"

The following pages link to Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. (Q43157289):

Displaying 26 items.

• Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography (Q26738576) (← links)
• Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption (Q31035087) (← links)
• Evaluation of Radiation Exposure to Staff and Environment Dose from [18F]-FDG in PET/CT and Cyclotron Center using Thermoluminescent Dosimetry (Q33592284) (← links)
• Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels (Q35062113) (← links)
• Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates (Q36055989) (← links)
• Imaging Radiation-Induced Gastrointestinal, Bone Marrow Injury and Recovery Kinetics Using 18F-FDG PET (Q36239543) (← links)
• Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments (Q36325435) (← links)
• Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on (18)F-FDG PET-CT for radiotherapy treatment planning (Q37392472) (← links)
• Radiation dose management in CT, SPECT/CT and PET/CT techniques (Q37897098) (← links)
• Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma. (Q38715665) (← links)
• Imaging modalities for characterising focal pancreatic lesions (Q38834240) (← links)
• Technological advances in hybrid imaging and impact on dose (Q41172687) (← links)
• Automated dispensing and calibration of diagnostic radiopharmaceuticals (Q43967986) (← links)
• Occupational per-patient radiation dose from a conservative protocol for veterinary (18) F-fluorodeoxyglucose positron emission tomography. (Q44461564) (← links)
• PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment (Q47669163) (← links)
• OCCUPATIONAL EXPOSURE FROM F-18-FDG PET/CT: IMPLEMENTATION TO ROUTINE CLINICAL PRACTICE. (Q49667057) (← links)
• A study on occupational exposure in a PET/CT facility (Q51166763) (← links)
• Radiation exposure to nuclear medicine staff involved in PET/CT practice in Serbia. (Q51237664) (← links)
• [PET-CT in head and neck cancer]. (Q52944077) (← links)
• No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer. (Q52982373) (← links)
• The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels. (Q52989901) (← links)
• Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided Biopsies. (Q55421083) (← links)
• 18F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study (Q84090243) (← links)
• [Principles of PET] (Q88417295) (← links)
• Texture analysis of pretreatment [18F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy (Q90070529) (← links)
• Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation (Q90455305) (← links)